4.7 Article

Interaction between the obesity-risk gene FTO and the dopamine D2 receptor gene ANKK1/TaqIA on insulin sensitivity

Journal

DIABETOLOGIA
Volume 59, Issue 12, Pages 2622-2631

Publisher

SPRINGER
DOI: 10.1007/s00125-016-4095-0

Keywords

ANKK1; Body fat; Dopamine; FTO; Insulin sensitivity; TaqIA

Funding

  1. Federal Ministry of Education and Research (BMBF) [01GI0925]
  2. Helmholtz Alliance ICEMED-Imaging and Curing Environmental Metabolic Diseases
  3. EFSD Rising Star award - Novo Nordisk
  4. Swedish Research Council
  5. Linne grant
  6. ERC [269045]
  7. Albert Pahlsson Foundation
  8. Bo & Kerstin Hjelt Diabetes Foundation
  9. European Research Council (ERC) [269045] Funding Source: European Research Council (ERC)

Ask authors/readers for more resources

Variations in FTO are the strongest common genetic determinants of adiposity, and may partly act by influencing dopaminergic signalling in the brain leading to altered reward processing that promotes increased food intake. Therefore, we investigated the impact of such an interaction on body composition, and peripheral and brain insulin sensitivity. Participants from the Tubingen Family study (n = 2245) and the Malmo Diet and Cancer study (n = 2921) were genotyped for FTO SNP rs8050136 and ANKK1 SNP rs1800497. Insulin sensitivity in the caudate nucleus, an important reward area in the brain, was assessed by fMRI in 45 participants combined with intranasal insulin administration. We found evidence of an interaction between variations in FTO and an ANKK1 polymorphism that associates with dopamine (D2) receptor density. In cases of reduced D2 receptor availability, as indicated by the ANKK1 polymorphism, FTO variation was associated with increased body fat and waist circumference and reduced peripheral insulin sensitivity. Similarly, altered central insulin sensitivity was observed in the caudate nucleus in individuals with the FTO obesity-risk allele and diminished D2 receptors. The effects of variations in FTO are dependent on dopamine D2 receptor density (determined by the ANKK1 polymorphism). Carriers of both risk alleles might, therefore, be at increased risk of obesity and diabetes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available